The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
HLA-DRB1
DOI:
10.1016/j.ebiom.2021.103431
Publication Date:
2021-06-19T06:11:50Z
AUTHORS (17)
ABSTRACT
BackgroundHLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk type 1 diabetes (T1D); however, some neutral or resistant. The pathobiological mechanism HLA-DR4 remains to be elucidated.MethodsWe used population-based case-control study T1D (962 patients and 636 controls) decipher genetic associations specific residues susceptibility T1D. Using birth cohort 7865 children periodically measured islet autoantibodies (GADA, IAA IA-2A), we proposed validate discovered totally different design time-to-seroconversions prior clinical onset A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity identified critical amino acid minimizing local genomic architecture higher-order interactions.FindingsThree (β71, β74, β86) were found predictive in study. "KAG" motif, corresponding HLA-DRB1×04:01, was most ([O]dds [R]atio=3.64, p = 3.19 × 10−64). Three less frequent motifs ("EAV", OR 2.55, 0.025; "RAG", 1.93, 0.043; "RAV", 1.56, 0.003) risk, while two ("REG" "REV") equally protective (OR 0.11, 4.23 10−4). In an independent HLA-DR3 subjects, those having motif had increased for time-to-seroconversion (Hazard Ratio 1.74, 6.51 10−14) after adjusting potential confounders.InterpretationsDNA variation at positions β71, β86 non-conservative (β74 A→E, β71 E vs K R G V). They result substantial differences peptide anchor pocket preferences p1, p4 potentially neighboring regions such as p7. Differential binding is likely affected. These substitutions may account contribution illustrated HLA-peptide model complexes autoantigens preproinsulin GAD65.FundingNational Institute Diabetes Digestive Kidney Diseases Swedish Child Foundation Research Council.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (13)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....